stars 1 stars 2 stars 3

SK Biopharmaceuticals is a part of the global conglomerate SK Group, the second largest company in Korea. We’re responsible for the development of innovative next-generation drugs within SK Group. SK Biopharmaceuticals has been developing many new drug candidates in the area of CNS, led by the clinical development center(SK Life Science) located in United States and the research center in Pangyo Techno-valley, Gyeonggi-do. With the experience and expertise in the CNS area, SK Biopharmaceuticals will continue to thrive as a successful new drug development company and become a trusted partner through its global R&D network. By 2020, SK Biopharmaceuticals envisions to grow into a global Fully Integrated Pharmaceutical Company (FIPCO) with streamlined capabilities from research to marketing. For more information, visit our website at www.skbp.com.

View Top Employees from SK Biopharmaceuticals

SK Biopharmaceuticals Questions

The SK Biopharmaceuticals annual revenue was $10 million in 2024.

Donghoon Lee is the CEO of SK Biopharmaceuticals.

152 people are employed at SK Biopharmaceuticals.

SK Biopharmaceuticals is based in Seongnam-si, Gyeonggi-do.

The NAICS codes for SK Biopharmaceuticals are [325, 54, 32, 3254, 32541, 325414, 541].

The SIC codes for SK Biopharmaceuticals are [283, 28].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users